MSB 4.89% $1.07 mesoblast limited

Ann: Mesoblast Type A Meeting with FDA, page-227

  1. 145 Posts.
    lightbulb Created with Sketch. 139
    Cyclopharm (CYC) received approval today through the FDA, this was after previously receiving a CRL similar to MSB.

    This is simply a delay to MSB and as shown with CYC there is light at the end of the tunnel and a huge addressable market. I can't wait until MSB get a letter like the below:

    https://hotcopper.com.au/data/attachments/5622/5622123-f6bf886c65d25c88634f581fede88347.jpg

    Last edited by Wanderdog: 02/10/23
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.